文献速递脊柱脊髓外科

经皮脊柱内镜治疗椎体强化术后新发腰骶部疼痛的临床研究

Clinical Study on Percutaneous Spinal Endoscopic Treatment for New-Onset Lumbosacral Pain Following Vertebral Augmentation Procedures.
PubMed 文献 · World Neurosurg · 2025-12-11

单中心回顾性队列纳入64例椎体强化术后新发腰腿痛患者,按影像分为椎间孔狭窄组、骨块压迫组和骨水泥渗漏压迫组,均行全内镜减压术。各组末次随访疼痛与功能评分较术前显著改善,骨水泥渗漏组手术时间较长、初期恢复较慢但远期疗效相当,MacNab优良率分别为85.7%、81.8%和66.7%,无手术并发症。

要点

  • 椎体强化术后新发腰腿痛可按影像分为椎间孔狭窄、骨块压迫、骨水泥渗漏压迫三型。
  • 全内镜减压术对三型均安全有效,骨水泥渗漏压迫组远期疗效与其他组相当。
  • 骨水泥渗漏压迫组手术时间较长、初期恢复较慢,但无手术并发症报告。

核心结论

  • 脊柱内镜减压是治疗椎体强化术后新发疼痛综合征安全、有效且微创的方法,可快速恢复并显著缓解症状。

研究设计与样本

  • 单中心回顾性队列研究,纳入64例椎体强化术后新发腰腿痛患者,按术前影像分为椎间孔狭窄组(A组)、骨块压迫组(B组)和骨水泥渗漏压迫组(C组),均行全内镜减压手术。

主要发现

  • 各组末次随访时背痛视觉模拟评分、腿痛视觉模拟评分和Oswestry功能障碍指数评分较术前均显著改善。
  • C组手术时间较长且初期恢复较慢,但远期结局与其他组相当。
  • MacNab标准优良率:A组85.7%,B组81.8%,C组66.7%,未报告手术并发症。

临床怎么用

  • 对椎体强化术后新发腰腿痛患者,可依据术前影像分型选择经皮脊柱内镜减压术。
  • 骨水泥渗漏压迫型患者需注意手术时间可能较长、初期恢复较慢,但远期疗效可期。

局限性

  • 单中心回顾性队列设计,样本量64例,可能存在选择偏倚与回顾性偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: This study investigated the feasibility of using percutaneous spinal endoscopic decompression to treat new-onset low back and leg pain in patients who had previously undergone vertebral augmentation procedures (VAP) for osteoporotic vertebral compression fractures. METHODS: A single-center retrospective cohort study was conducted on 64 patients who developed new-onset pain symptoms after VAP. Based on preoperative imaging findings, patients were categorized into three groups: Group A (foraminal stenosis), Group B (bone fragment compression), and Group C (bone cement leakage compression). All patients underwent full endoscopic decompression surgery to relieve pressure on the spinal cord or nerve roots. RESULTS: Clinical outcomes, measured by back pain visual analog scale, leg pain visual analog scale, and Oswestry Disability Index scores, were assessed preoperatively and at multiple postoperative intervals. All groups showed significant improvement in scores at the final follow-up compared to their pre-operative state. While Group C had a longer operative time and slower initial recovery, its long-term outcomes were comparable to the other groups. The overall excellent/good rate on the MacNab criteria was high (Group A: 85.7%, B: 81.8%, C: 66.7%), with no surgical complications reported. CONCLUSION: The study concludes that spinal endoscopic decompression is a safe, effective, and minimally invasive treatment for this specific post-VAP pain syndrome, offering rapid recovery and significant symptom relief.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Bu J, He Y, Wang Z, et al. Clinical Study on Percutaneous Spinal Endoscopic Treatment for New-Onset Lumbosacral Pain Following Vertebral Augmentation Procedures. World Neurosurg. 2025. PMID: 41390077. doi:10.1016/j.wneu.2025.124722

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。